首页> 美国卫生研究院文献>other >Dendrimers-drug conjugates for tailored intracellular drug release based on glutathione levels
【2h】

Dendrimers-drug conjugates for tailored intracellular drug release based on glutathione levels

机译:树状聚合物-药物共轭物可根据谷胱甘肽水平调节细胞内药物释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

N-Acetyl-L-Cysteine (NAC) is an anti-oxidant and anti-inflammatory agent with significant potential in clinical applications including stroke and neuroinflammation. The drug shows high plasma binding upon IV administration, requiring high doses and associated side effects. Through the use of an appropriate delivery vehicle, the stability and efficacy of NAC can be significantly improved. Dendrimers are an emerging class of nanoscale drug delivery vehicles, which enable high drug payloads and intracellular delivery. Poly(amidoamine) dendrimer-NAC conjugates having cleavable disulfide linkages are designed for intracellular delivery based on glutathione levels. We have successfully synthesized two conjugates of with a cationic G4-NH2 and an anionic G3.5-COOH PAMAM dendrimers with NAC payloads of 16 and 18 per dendrimer, respectively, as confirmed by 1H-NMR and MALDI-TOF analysis. NAC release kinetics of the conjugates at intracellular and extracellular Glutathione (GSH) concentrations were evaluated by reverse phase HPLC (RP-HPLC) analysis, and ~70% of NAC payload was released within one hour at intracellular GSH concentrations (~10 mM), whereas negligible NAC release was observed at extracellular GSH levels (2 µM). FITC-labeled conjugates showed that they enter cells rapidly and localize in the cytoplasm of lipopolysaccharide (LPS)-activated microglial cells (the target cells in vivo). The efficacies of dendrimer-NAC conjugates in activated microglial cells was confirmed by measuring the nitrite inhibition in the cell culture medium, which is an indication of the anti-oxidative property of the drug.Both G4-NH2 and G3.5-COOH conjugates showed more significantly better nitrite inhibition both at 24 and 72 hours compared to free NAC, by as much as a factor of 16. The results indicate that PAMAM dendrimer conjugates produce a higher local NAC concentration inside the cells, with GSH-sensitive disulfide linker enabling efficient and rapid cellular release of the drug.
机译:N-乙酰基-L-半胱氨酸(NAC)是一种抗氧化剂和消炎剂,在包括卒中和神经炎症在内的临床应用中具有巨大潜力。该药物在静脉内给药后显示出高血浆结合性,需要高剂量和相关的副作用。通过使用适当的递送载体,可以显着改善NAC的稳定性和功效。树状聚合物是一类新兴的纳米级药物递送载体,其能够实现高药物有效负载和细胞内递送。具有可裂解的二硫键的聚(酰胺基胺)树状聚合物-NAC缀合物被设计用于基于谷胱甘肽水平的细胞内递送。 1 H-NMR和NMR证实,我们已经成功合成了两种阳离子共轭物,分别具有阳离子G4-NH2和阴离子G3.5-COOH PAMAM树状聚合物,每个树状聚合物的NAC有效载荷分别为16和18。 MALDI-TOF分析。通过反相HPLC(RP-HPLC)分析评估了缀合物在细胞内和细胞外谷胱甘肽(GSH)浓度下的NAC释放动力学,在细胞内GSH浓度(〜10 mM)下,一小时内释放了约70%的NAC有效负载,而在细胞外GSH水平(2 µM)观察到的NAC释放可忽略不计。 FITC标记的偶联物显示它们迅速进入细胞并定位在脂多糖(LPS)激活的小胶质细胞(体内靶细胞)的细胞质中。通过测量细胞培养基中的亚硝酸盐抑制作用来证实树状聚合物-NAC缀合物在活化的小胶质细胞中的功效,这表明该药物具有抗氧化性能.G4-NH2和G3.5-COOH缀合物均显示与游离NAC相比,在24小时和72小时时亚硝酸盐的抑制效果更好,提高了约16倍。结果表明,PAMAM树状聚合物偶联物在细胞内产生较高的局部NAC浓度,而GSH敏感的二硫键可实现高效和药物的快速细胞释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号